AHG Valuation

Akso Health Group

Add to Watchlist

Advanced Chart

1.700

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

AHG Relative Valuation

AHG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AHG is overvalued; if below, it's undervalued.

Historical Valuation

Akso Health Group (AHG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 0.66 is considered Undervalued compared with the five-year average of 0.52. The fair price of Akso Health Group (AHG) is between 34.31 to 35.85 according to relative valuation methord. Compared to the current price of 1.70 USD , Akso Health Group is Undervalued By 95.05%.

Relative Value

Fair Zone

34.31-35.85

Current Price：1.70

95.05%

Undervalued

0.66

Trailing

Forward

0.00

EV/EBITDA

Akso Health Group. (AHG) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

16.25

EV/EBIT

Akso Health Group. (AHG) has a current EV/EBIT of 16.25. The 5-year average EV/EBIT is 2.04. The thresholds are as follows: Strongly Undervalued below -4.04, Undervalued between -4.04 and -1.00, Fairly Valued between 5.08 and -1.00, Overvalued between 5.08 and 8.11, and Strongly Overvalued above 8.11. The current Forward EV/EBIT of 16.25 falls within the Strongly Overvalued range.

9.54

Akso Health Group. (AHG) has a current PS of 9.54. The 5-year average PS is 1.17. The thresholds are as follows: Strongly Undervalued below -2.37, Undervalued between -2.37 and -0.60, Fairly Valued between 2.94 and -0.60, Overvalued between 2.94 and 4.71, and Strongly Overvalued above 4.71. The current Forward PS of 9.54 falls within the Strongly Overvalued range.

29.61

P/OCF

Akso Health Group. (AHG) has a current P/OCF of 29.61. The 5-year average P/OCF is 3.63. The thresholds are as follows: Strongly Undervalued below -7.35, Undervalued between -7.35 and -1.86, Fairly Valued between 9.12 and -1.86, Overvalued between 9.12 and 14.61, and Strongly Overvalued above 14.61. The current Forward P/OCF of 29.61 falls within the Strongly Overvalued range.

30.81

P/FCF

Akso Health Group. (AHG) has a current P/FCF of 30.81. The 5-year average P/FCF is 3.78. The thresholds are as follows: Strongly Undervalued below -7.65, Undervalued between -7.65 and -1.93, Fairly Valued between 9.49 and -1.93, Overvalued between 9.49 and 15.21, and Strongly Overvalued above 15.21. The current Forward P/FCF of 30.81 falls within the Strongly Overvalued range.

Akso Health Group (AHG) has a current Price-to-Book (P/B) ratio of 4.71. Compared to its 3-year average P/B ratio of 1.79 , the current P/B ratio is approximately 163.14% higher. Relative to its 5-year average P/B ratio of 2.00, the current P/B ratio is about 136.07% higher. Akso Health Group (AHG) has a Forward Free Cash Flow (FCF) yield of approximately 0.11%. Compared to its 3-year average FCF yield of -7.78%, the current FCF yield is approximately -101.39% lower. Relative to its 5-year average FCF yield of -5.10% , the current FCF yield is about -102.12% lower.

4.71

P/B

Median3y

1.79

Median5y

2.00

0.11

FCF Yield

Median3y

-7.78

Median5y

-5.10

Competitors Valuation Multiple

The average P/S ratio for AHG's competitors is 2.57, providing a benchmark for relative valuation. Akso Health Group Corp (AHG) exhibits a P/S ratio of 9.54, which is 271.66% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Liquidity Services Inc

Performance Decomposition

Market capitalization of AHG increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of AHG in the past 1 year is driven by Unknown.